Acarbose effects on vascular stiffness in patients with arterial hypertension and metabolic syndrome
Aim. To assess perspectives of pulse wave velocity (PWV) correction during acarbose treatment in patients with impaired glucose tolerance (IGT) and arterial hypertension (AH). Material and methods. An open clinical trial included 45 patients (18 males and 27 females) aged 18-60 years, with body mass...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2006-04-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1128 |
_version_ | 1797882761164357632 |
---|---|
author | S. V. Nedogoda V. A. Tsoma I. N. Barykina G. V. Mazina U. A. Brel T. A. Chalyabi V. B. Mychka I. E. Chazova |
author_facet | S. V. Nedogoda V. A. Tsoma I. N. Barykina G. V. Mazina U. A. Brel T. A. Chalyabi V. B. Mychka I. E. Chazova |
author_sort | S. V. Nedogoda |
collection | DOAJ |
description | Aim. To assess perspectives of pulse wave velocity (PWV) correction during acarbose treatment in patients with impaired glucose tolerance (IGT) and arterial hypertension (AH). Material and methods. An open clinical trial included 45 patients (18 males and 27 females) aged 18-60 years, with body mass index (BMI) > 25 kg/m2, IGT, and elevated blood pressure (BP). After envelope method randomization, all patients were divided into three groups: active acarbose treatment groups (maximal dose 150 mg/d or 300 mg/d) and previous therapy group. In all groups, non-pharmaceutical lifestyle modification and weight control measures were performed (diet, increased physical activity). Treatment phase lasted for 24 weeks. Dynamics of BP, carbohydrate and lipid metabolism, PWV for vessels of various diameters, by Complior protocol and with Colson device, were registered. Results. Acarbose treatment resulted not only in carbohydrate and lipid metabolism improvement, but also in artery elasticity improvement among overweight patients with IGT. Conclusion. In patients with IGT and excess body weight, acarbose in doses of 150-300 mg/d, added to nonpharmaceutical intervention, was associated with PWV normalization, and could be regarded as a sign of beneficial acarbose influence on large vessel elasticity. |
first_indexed | 2024-04-10T03:40:53Z |
format | Article |
id | doaj.art-bfc0060c56bc487bbf921902e28546a2 |
institution | Directory Open Access Journal |
issn | 1728-8800 2619-0125 |
language | Russian |
last_indexed | 2024-04-10T03:40:53Z |
publishDate | 2006-04-01 |
publisher | «SILICEA-POLIGRAF» LLC |
record_format | Article |
series | Кардиоваскулярная терапия и профилактика |
spelling | doaj.art-bfc0060c56bc487bbf921902e28546a22023-03-13T07:23:12Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252006-04-01524045840Acarbose effects on vascular stiffness in patients with arterial hypertension and metabolic syndromeS. V. Nedogoda0V. A. Tsoma1I. N. Barykina2G. V. Mazina3U. A. Brel4T. A. Chalyabi5V. B. Mychka6I. E. Chazova7Волгоградский государственный медицинский университет. ВолгоградВолгоградский государственный медицинский университет. ВолгоградВолгоградский государственный медицинский университет. ВолгоградВолгоградский государственный медицинский университет. ВолгоградВолгоградский государственный медицинский университет. ВолгоградВолгоградский государственный медицинский университет. ВолгоградНИИ клинической кардиологии им. А.Л.Мясникова Российского кардиологического научно-производственного комплекса Росздрава. МоскваНИИ клинической кардиологии им. А.Л.Мясникова Российского кардиологического научно-производственного комплекса Росздрава. МоскваAim. To assess perspectives of pulse wave velocity (PWV) correction during acarbose treatment in patients with impaired glucose tolerance (IGT) and arterial hypertension (AH). Material and methods. An open clinical trial included 45 patients (18 males and 27 females) aged 18-60 years, with body mass index (BMI) > 25 kg/m2, IGT, and elevated blood pressure (BP). After envelope method randomization, all patients were divided into three groups: active acarbose treatment groups (maximal dose 150 mg/d or 300 mg/d) and previous therapy group. In all groups, non-pharmaceutical lifestyle modification and weight control measures were performed (diet, increased physical activity). Treatment phase lasted for 24 weeks. Dynamics of BP, carbohydrate and lipid metabolism, PWV for vessels of various diameters, by Complior protocol and with Colson device, were registered. Results. Acarbose treatment resulted not only in carbohydrate and lipid metabolism improvement, but also in artery elasticity improvement among overweight patients with IGT. Conclusion. In patients with IGT and excess body weight, acarbose in doses of 150-300 mg/d, added to nonpharmaceutical intervention, was associated with PWV normalization, and could be regarded as a sign of beneficial acarbose influence on large vessel elasticity.https://cardiovascular.elpub.ru/jour/article/view/1128артериальная гипертензиянарушенная толерантность к глюкозеизбыточная масса теласосудистая жесткостьскорость распространения пульсовой волныакарбоза |
spellingShingle | S. V. Nedogoda V. A. Tsoma I. N. Barykina G. V. Mazina U. A. Brel T. A. Chalyabi V. B. Mychka I. E. Chazova Acarbose effects on vascular stiffness in patients with arterial hypertension and metabolic syndrome Кардиоваскулярная терапия и профилактика артериальная гипертензия нарушенная толерантность к глюкозе избыточная масса тела сосудистая жесткость скорость распространения пульсовой волны акарбоза |
title | Acarbose effects on vascular stiffness in patients with arterial hypertension and metabolic syndrome |
title_full | Acarbose effects on vascular stiffness in patients with arterial hypertension and metabolic syndrome |
title_fullStr | Acarbose effects on vascular stiffness in patients with arterial hypertension and metabolic syndrome |
title_full_unstemmed | Acarbose effects on vascular stiffness in patients with arterial hypertension and metabolic syndrome |
title_short | Acarbose effects on vascular stiffness in patients with arterial hypertension and metabolic syndrome |
title_sort | acarbose effects on vascular stiffness in patients with arterial hypertension and metabolic syndrome |
topic | артериальная гипертензия нарушенная толерантность к глюкозе избыточная масса тела сосудистая жесткость скорость распространения пульсовой волны акарбоза |
url | https://cardiovascular.elpub.ru/jour/article/view/1128 |
work_keys_str_mv | AT svnedogoda acarboseeffectsonvascularstiffnessinpatientswitharterialhypertensionandmetabolicsyndrome AT vatsoma acarboseeffectsonvascularstiffnessinpatientswitharterialhypertensionandmetabolicsyndrome AT inbarykina acarboseeffectsonvascularstiffnessinpatientswitharterialhypertensionandmetabolicsyndrome AT gvmazina acarboseeffectsonvascularstiffnessinpatientswitharterialhypertensionandmetabolicsyndrome AT uabrel acarboseeffectsonvascularstiffnessinpatientswitharterialhypertensionandmetabolicsyndrome AT tachalyabi acarboseeffectsonvascularstiffnessinpatientswitharterialhypertensionandmetabolicsyndrome AT vbmychka acarboseeffectsonvascularstiffnessinpatientswitharterialhypertensionandmetabolicsyndrome AT iechazova acarboseeffectsonvascularstiffnessinpatientswitharterialhypertensionandmetabolicsyndrome |